Generation Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.

About GBIO

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. 

CEO
Cameron Geoffrey McDonough
CEOCameron Geoffrey McDonough
Employees
115
Employees115
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2016
Founded2016
Employees
115
Employees115

GBIO Key Statistics

Market cap
27.34M
Market cap27.34M
Price-Earnings ratio
-0.48
Price-Earnings ratio-0.48
Dividend yield
Dividend yield
Average volume
1.97M
Average volume1.97M
High today
$0.5781
High today$0.5781
Low today
$0.3808
Low today$0.3808
Open price
$0.44
Open price$0.44
Volume
4.60M
Volume4.60M
52 Week high
$3.65
52 Week high$3.65
52 Week low
$0.3004
52 Week low$0.3004

Analyst ratings

67%

of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own GBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.